Détention brevets de la classe A61K 31/4738

Brevets de cette classe: 180

Historique des publications depuis 10 ans

5
7
11
5
8
18
16
12
10
4
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

Propriétaires principaux

Proprétaire
Total
Cette classe
Corcept Therapeutics, Inc.
348
5
Neurocrine Biosciences, Inc.
425
5
Korea University Research and Business Foundation, Sejong Campus
166
5
Coley Pharmaceutical Group, Inc.
34
4
Pharma Mar, S.A.
215
4
AstraZeneca AB
2857
3
Epizyme, Inc.
374
3
Hoffmann-La Roche Inc.
3516
2
Merck Sharp & Dohme Corp.
2190
2
The Board of Trustees of the University of Illinois
2713
2
University of Florida Research Foundation, Inc.
4074
2
Board of Supervisors of Louisiana State University and Agricultural and Mechanical College
824
2
Children's Medical Center Corporation
1906
2
Demerx, Inc.
75
2
Emory University
1651
2
Jiangsu Hansoh Pharmaceutical Group Co., Ltd.
309
2
Korea Research Institute of Bioscience and Biotechnology
1060
2
OsteoGeneX Inc.
12
2
Regents of the University of Minnesota
2723
2
Schering Corporation
418
2
Autres propriétaires 125